Skip to main content

Purple Biotech Ltd.

PPBT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001614744

No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Purple Biotech Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
13
−2 vs. Q1 2026
Shares held
84.4K
+8.76K (+11.6%) vs. Q1 2026
Total value
$141.0K
−$164.6K (−53.9%) vs. Q1 2026
New holders
5
4 more added
Sold out
7
3 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PPBT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 13 institutions
Q1 2021: 15 institutionsQ2 2021: 13 institutionsQ3 2021: 12 institutionsQ4 2021: 13 institutionsQ1 2022: 14 institutionsQ2 2022: 14 institutionsQ3 2022: 11 institutionsQ4 2022: 15 institutionsQ1 2023: 16 institutionsQ2 2023: 17 institutionsQ3 2023: 18 institutionsQ4 2023: 20 institutionsQ1 2024: 21 institutionsQ2 2024: 21 institutionsQ3 2024: 11 institutionsQ4 2024: 14 institutionsQ1 2025: 9 institutionsQ2 2025: 14 institutionsQ3 2025: 16 institutionsQ4 2025: 19 institutionsQ1 2026: 15 institutionsQ2 2026: 13 institutions
Value heldQ2 2026: $141.0K
Q1 2021: $2.40MQ2 2021: $3.72MQ3 2021: $5.27MQ4 2021: $4.22MQ1 2022: $1.77MQ2 2022: $311.2KQ3 2022: $224.0KQ4 2022: $239.6KQ1 2023: $224.2KQ2 2023: $388.3KQ3 2023: $275.9KQ4 2023: $1.97MQ1 2024: $1.95MQ2 2024: $776.3KQ3 2024: $946.3KQ4 2024: $377.9KQ1 2025: $134.3KQ2 2025: $133.7KQ3 2025: $75.9KQ4 2025: $513.2KQ1 2026: $305.6KQ2 2026: $141.0K
Institutions holding PPBT and their total value by quarter
QuarterHoldersValue
Q2 202613$141.0K
Q1 202615$305.6K
Q4 202519$513.2K
Q3 202516$75.9K
Q2 202514$133.7K
Q1 20259$134.3K
Q4 202414$377.9K
Q3 202411$946.3K
Q2 202421$776.3K
Q1 202421$1.95M
Q4 202320$1.97M
Q3 202318$275.9K
Q2 202317$388.3K
Q1 202316$224.2K
Q4 202215$239.6K
Q3 202211$224.0K
Q2 202214$311.2K
Q1 202214$1.77M
Q4 202113$4.22M
Q3 202112$5.27M
Q2 202113$3.72M
Q1 202115$2.40M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Purple Biotech Ltd.; share changes are against Q1 2026.

Institutions holding PPBT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
SmartHarvest Portfolios, LLC28,468$47.8K0.02%+10,341+57.0%Added
HRT Financial LP14,640$24.0K0.00%+14,640New
Citadel Advisors LLC13,166$22.1K0.00%+13,166New
Susquehanna International Group, LLP12,847$21.6K0.00%−40,556−75.9%Reduced
Independent Advisor Alliance11,901$20.0K0.00%+11,901New
SRS Capital Advisors, Inc.1,453$2.44K0.00%+1,453New
Rhumbline Advisers856$1.44K0.00%+146+20.6%Added
UBS Group AG751$1.26K0.00%+652+658.6%Added
Morgan Stanley197$3310.00%−381−65.9%Reduced
Northwestern Mutual Wealth Management Co8$130.00%00.0%Unchanged
IFG Advisory, LLC7$120.00%+7New
SBI Securities Co., Ltd.3$50.00%−28−90.3%Reduced
Royal Bank of Canada128$00.00%+118+1,180.0%Added
BNP Paribas Arbitrage, SA0$00.00%−1,957−100.0%Sold out
Simplex Trading, LLC0$00.00%−597−100.0%Sold out
GAMMA Investing LLC0$00.00%−108−100.0%Sold out
Group One Trading, L.P.0$00.00%−20−100.0%Sold out
Advisory Services Network, LLC0$00.00%−9−100.0%Sold out
Jones Financial Companies LLLP0$00.00%−5−100.0%Sold out
Danske Bank A/S0$00.00%−4−100.0%Sold out